AIMCA
DAWN

Alberta Investment Management Corp (AIMCo)’s Day One Biopharmaceuticals DAWN Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200,000
Closed -$4.29M – 683
2026
Q1 		$4.29M Buy
+200,000
New +$2.82M 0.03% 313

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s DAWN Position: Q2 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 200,000 shares — an estimated $4.29M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $4.29M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 200,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $4.29M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Day One Biopharmaceuticals position peaked at $4.29M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2026, filed 6 Aug 2026.